- CompBioMed and Coronavirus
Read about CompBioMed's urgent coronavirus research
- Coronavirus: Computational Drug Discovery
CompBioMed is identifying promising coronavirus drug targets
- Coronavirus: Call for Contributions
We are seeking contributions to our coronavirus research
- Coronavirus: Research Resources
We have compiled a comprehensive list of other groups working on the coronavirus and offer links to these.
CompBioMed is active in a vast international consortium across Europe and USA working on urgent coronavirus research. The consortium is redirecting substantial research effort and funding on computational investigations that will improve our understanding of the SARS-CoV-2 virus and the associated COVID-19 disease, and accelerate the development of treatment options, including antiviral drugs and vaccines. Read more about it here.
CompBioMed 2 started on 1st October 2019 and will run for another 4 years.
- How to Build the Virtual Human
Now available on CompBioMed YouTube channel, and embedded on our site
- Latest results
Research work published by our partners. Links to full papers and summaries if you're short of time
CompBioMed is a European Commission H2020 funded Centre of Excellence focused on the use and development of computational methods for biomedical applications. We have users within academia, industry and clinical environments and are working to train more people in the use of our products and methods. Below you will find links to the user pages, which will give you more information on the work we are doing, relevant to your field, and our services which may provide further information on our work. A great introduction is the Virtual Humans film (link to YouTube) , or through the link in the scrolling banner above.
- The World’s Fastest Computer to Join Fight Against COVID-19
In our previous blog posts we have highlighted in the work of the Argonne National Laboratory (ANL) and Barcelona Supercomputing Center (BSC) that High Performance Computing (HPC) resources are an…
- AI-driven integrative biology for accelerating therapeutic drug discoveries to treat SARS-CoV-2
CompBioMed partners and academics from other research facilities are carrying out research to address the fundamental biological mechanisms of both the SARS-CoV-2 novel corona virus and the COVID-19 disease it…
- Cardiotoxicity: Supercomputer-based in silico studies by CompBioMed Core Partners aiming to make COVID-19 treatment safer for the heart
The use of certain drugs can disturb the rhythm at which hearts beat. This disruption can have toxic effects on the heart, which are particularly dangerous for those with underlying…
- 3-year PhD studentship in the simulation of chaotic systems
The Centre for Computational Science (CCS) of University College London (UCL) in collaboration with CBK Sci Con are offering a fully-funded studentship to a highly motivated candidate to start in…
- Repurposing Existing Drugs in the Fight Against COVID-19
The use of existing pharmaceutical to treat COVID-19 has several potential benefits over the development of new drugs from the group up, not least that much shorter clinical trials would…
- Coronavirus Resources Across CompBioMed
Here at CoronaBlog, where we will be providing regular news and updates on the research activities of the CompBioMed members, their collaborators, and the wider scientific community, we have established…
- Webinar on how AI in Computational Medicine is Leading The Charge in COVID-19 Drug Discovery
There are tens, perhaps hundreds of billions of compounds which can be utilised by the pharmaceutical industry in the development of new drugs. An exhaustive exploration of more than a…
- Introducing the CoronaBlog
The ongoing coronavirus pandemic is having a profound impact on how we go about our day to day lives and is dominating world news and conversation (conducted from the recommended…
- CompBioMed and Coronavirus
CompBioMed is active in a vast international consortium across Europe and USA working on urgent coronavirus research. Heading CompBioMed’s efforts in this collaboration is Prof Peter Coveney and the Centre…
- Toward the first full scale virtual human simulation at the exascale.
A major effort is now underway to perform the first full scale 3-D high fidelity simulations of blood flow in the human vasculature. Led by Peter Coveney within his Centre…